Home Tags Kelun-Biotech

Tag: Kelun-Biotech

Merck & Co Announces Phase 3 Trial Initiations for MK-2870/SKB264

Merck & Co/MSD has initiated a pivotal Phase 3 trials for of its investigational antibody-drug conjugates (ADC) candidate MK-2870/SKB264, an innovative TROP2-targeting ADC being...

Kelun-Biotech Signs Oncology Research Collaboration Agreement with Merck/MSD

Chinese clinical-stage biotech company Kelun-Biotech*,  a subsidiary of Sichuan Kelun Pharmaceutical, has signed an exclusive license agreement with Merck & Co/MSD to develop an...